Literature DB >> 6397028

Residual B-cell function in type 1 (insulin-dependent) diabetes mellitus: its relation to clinical and metabolic features.

E Bonora, C Coscelli, U Butturini.   

Abstract

The aim of the present study was to investigate whether or not residual B-cell function could be related to insulin sensitivity as well as to duration of disease, insulin requirement, and indices of metabolic control in a population of Type 1 (insulin-dependent) diabetic patients. A positive correlation was found between fasting C-peptide and age at onset of diabetes, whereas a negative relationship occurred between C-peptide and duration of disease. Fasting C-peptide negatively correlated also to mean daily plasma glucose, 24-h glycosuria, and fasting free fatty acid concentration. Moreover, a negative correlation was found between C-peptide and daily insulin requirement. Conversely, a positive relationship occurred between C-peptide levels and the parameter we used for estimating insulin sensitivity, i.e. glucose disappearance rate after i.v. insulin injection. These results once more emphasize the importance of residual B-cell function in Type 1 (insulin-dependent) diabetes mellitus, and suggest that the residual endogenous insulin secretion might play an important role in glucose homeostasis of Type 1 diabetes by influencing the sensitivity to insulin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6397028     DOI: 10.1007/BF02582092

Source DB:  PubMed          Journal:  Acta Diabetol Lat        ISSN: 0001-5563


  31 in total

1.  Circulating serum C-peptide. A brief review of diagnostic implications.

Authors:  D L Horwitz; H Kuzuya; A H Rubenstein
Journal:  N Engl J Med       Date:  1976-07-22       Impact factor: 91.245

2.  Studies on the etiology of "brittle diabetes". Relationship between diabetic instability and insulinogenic reserve.

Authors:  K Shima; R Tanaka; S Morishita; S Tarui; Y Kumahara
Journal:  Diabetes       Date:  1977-08       Impact factor: 9.461

3.  Radioimmunoelectrophoresis in the determination of insulin binding to IgG.

Authors:  A H Christiansen
Journal:  Horm Metab Res       Date:  1973-05       Impact factor: 2.936

4.  The significance and interpretation of mildly abnormal oral glucose tolerance.

Authors:  F P Alford; F I Martin; M J Pearson
Journal:  Diabetologia       Date:  1971-06       Impact factor: 10.122

Review 5.  Symposium I: hormone-fuel interactions in normal and diabetic man. The liver as site of insulin and glucagon action in normal, diabetic and obese humans.

Authors:  P Felig; J Wahren
Journal:  Isr J Med Sci       Date:  1975-06

6.  Clinical significance of altered insulin sensitivity in diabetes mellitus assessed by glucose, insulin, and somatostatin infusion.

Authors:  Y Harano; S Ohgaku; K Kosugi; H Yasuda; T Nakano; M Kobayashi; H Hidaka; K Izumi; A Kashiwagi; Y Shigeta
Journal:  J Clin Endocrinol Metab       Date:  1981-05       Impact factor: 5.958

7.  Insulin receptors on monocytes of young healthy persons correlated with glucose tolerance and insulin sensitivity.

Authors:  H Beck-Nielsen; O Pedersen
Journal:  Diabetologia       Date:  1978-03       Impact factor: 10.122

8.  C-peptide in juvenile diabetics beyond the postinitial remission period. Relation to clinical manifestations at onset of diabetes, remission and diabetic control.

Authors:  J Ludvigsson; L G Heding; Y Larsson; E Leander
Journal:  Acta Paediatr Scand       Date:  1977-03

9.  Prevalence of residual B-cell function in insulin-treated diabetics evaluated by the plasma C-etide response to intravenous glucagon.

Authors:  C Hendriksen; O K Faber; J Drejer; C Binder
Journal:  Diabetologia       Date:  1977-12       Impact factor: 10.122

10.  Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects.

Authors:  L C Harrison; F I Martin; R A Melick
Journal:  J Clin Invest       Date:  1976-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.